Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Northwest Biotherapeutics (NWBO) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Northwest Biotherapeutics (NWBO) over the last 17 years, with Q3 2025 value amounting to $358000.0.

  • Northwest Biotherapeutics' Other Non-Current Assets fell 427.81% to $358000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $358000.0, marking a year-over-year decrease of 427.81%. This contributed to the annual value of $365000.0 for FY2024, which is 110.8% up from last year.
  • Latest data reveals that Northwest Biotherapeutics reported Other Non-Current Assets of $358000.0 as of Q3 2025, which was down 427.81% from $370000.0 recorded in Q2 2025.
  • Northwest Biotherapeutics' 5-year Other Non-Current Assets high stood at $1.1 million for Q2 2021, and its period low was $339000.0 during Q3 2022.
  • In the last 5 years, Northwest Biotherapeutics' Other Non-Current Assets had a median value of $363000.0 in 2024 and averaged $507210.5.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first skyrocketed by 4476.82% in 2021, then plummeted by 6871.0% in 2022.
  • Over the past 5 years, Northwest Biotherapeutics' Other Non-Current Assets (Quarter) stood at $1.0 million in 2021, then plummeted by 66.7% to $345000.0 in 2022, then increased by 4.64% to $361000.0 in 2023, then rose by 1.11% to $365000.0 in 2024, then fell by 1.92% to $358000.0 in 2025.
  • Its Other Non-Current Assets stands at $358000.0 for Q3 2025, versus $370000.0 for Q2 2025 and $367000.0 for Q1 2025.